In the HSA synergism plots of cotreatment with cisplatin and azacytidine, clear synergistic zones were available in PEO1, PEO4, and OVCA433 cells, which represented a significant synergistic effect of cisplatin and azacytidine on the suppression of ovarian cancer cell growth (Fig. 6). The gene discussed is ALB; the disease is ovarian cancer.